Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Pollegioni L et al. | Cholesterol oxidase: biotechnological applications. | 2009 | FEBS J. | pmid:19843167 |
Rosłoniec KZ et al. | Cytochrome P450 125 (CYP125) catalyses C26-hydroxylation to initiate sterol side-chain degradation in Rhodococcus jostii RHA1. | 2009 | Mol. Microbiol. | pmid:19843222 |
Osborne DM and Frye CA | Estrogen increases latencies to seizures and levels of 5alpha-pregnan-3alpha-ol-20-one in hippocampus of wild-type, but not 5alpha-reductase knockout, mice. | 2009 | Epilepsy Behav | pmid:19782646 |
Schmidt LJ et al. | Effects of the 5 alpha-reductase inhibitor dutasteride on gene expression in prostate cancer xenografts. | 2009 | Prostate | pmid:19676081 |
Taplin ME et al. | Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer. | 2009 | Clin. Cancer Res. | pmid:19887483 |
Shimoda H et al. | The hypocholesterolemic effects of Cistanche tubulosa extract, a Chinese traditional crude medicine, in mice. | 2009 | Am. J. Chin. Med. | pmid:19938221 |
Xiao WH et al. | Olesoxime (cholest-4-en-3-one, oxime): analgesic and neuroprotective effects in a rat model of painful peripheral neuropathy produced by the chemotherapeutic agent, paclitaxel. | 2009 | Pain | pmid:19833436 |
Juan Escudero JU et al. | [Green light laser efficacy in patients with prostatic hyperplasia treatment with 5-alpha reductase inhibitors]. | 2009 | Actas Urol Esp | pmid:19925759 |
Capyk JK et al. | Mycobacterial cytochrome p450 125 (cyp125) catalyzes the terminal hydroxylation of c27 steroids. | 2009 | J. Biol. Chem. | pmid:19846551 |
Ditscheid B et al. | Faecal steroid excretion in humans is affected by calcium supplementation and shows gender-specific differences. | 2009 | Eur J Nutr | pmid:19009227 |